Performance of Diagnostic Criteria for Autoimmune Encephalitis in Patients With Suspected Rapidly Progressive Dementia
- 8 December 2026
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (11)
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- Early Recognition of Treatment‐Responsive Rapidly Progressive Dementia: The Modified STAM3 m P ScoreAnnals of Clinical and Translational Neurology, 2026
- Decoding the Clinical Features that Associate with Progression, Causes, and Outcomes in Patients with Suspected Rapidly Progressive DementiaAnnals of Neurology, 2025
- Diagnostic Utility of Cerebrospinal Fluid Biomarkers in Patients with Rapidly Progressive DementiaAnnals of Neurology, 2023
- Improving Early Recognition of Treatment‐Responsive Causes of Rapidly Progressive Dementia: The STAM3P ScoreAnnals of Neurology, 2023
- LGI1 antibody-associated encephalitis without evidence of inflammation in CSF and brain MRIActa Neurologica Belgica, 2022
- Flortaucipir (tau) PET in LGI1 antibody encephalitisAnnals of Clinical and Translational Neurology, 2021
- Association Between Immunosuppressive Treatment and Outcomes of Cerebral Amyloid Angiopathy–Related InflammationJAMA Neurology, 2020
- Diagnosing autoimmune encephalitis in a real-world single-centre settingJournal of Neurology, 2019
- Diagnosis and Management of Autoimmune DementiaCurrent Treatment Options in Neurology, 2019
- Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteriaMovement Disorders, 2017